Sandra Raff

Company: Ultragenyx Pharmaceutical Inc

Job title: Senior Director - Drug Safety & Pharmacovigilance

Seminars:

Panel Discussion: Understanding How to Best Conduct Long-Term Safety Monitoring 12:30 pm

• Assessing the current FDA guidelines • Reviewing how effective long-term follow up protocol is at truly understanding the long-term safety of AAV gene therapies • Strategize additional monitoring to better inform the long-term safety profileRead more

day: Day Two